Drug Giants Pay Hefty Premiums as Cancer-Drug Race Heats Up

(Bloomberg) -- Two of the world’s biggest pharmaceutical companies agreed to pay substantial premiums to acquire smaller cancer-drug makers, underlining the eagerness of the drug giants to add prom...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.